Page results
-
This page is about histiocytic disorders treated at the UCLH haematology department.
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
This page explains what you can expect during recovery from your CAR T-cell therapy.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using hybrid closed loop (HCL) systems.
-
School training dates for September 2020 including an Eventbrite link
-
I would like to make a payment to UCLH, I have a query about reclaiming expenses for treatment or transport at University College Hospital or I have a query about expenses for treatment or transport at Queen Square (NHNN/RLHIM)
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
This page provides information for employers, teachers, special needs education coordinators (SENCo) and other professionals who work alongside someone with Galactosaemia.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
File results
-
FOI/2022/0254 - Patient treatment/ surgery
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0267 - Performance data for the CCG2 CQUIN - Antibiotic prescribing for UTI in adults aged 16+
-
FOI/2022/0270 - Local care record/ shared care record implementation
-
FOI/2022/0274 - Patient treatment for various conditions
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0278 - Surgical tables in use at Trust
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0282 - Decontamination and infection control leads; risk assessment group meetings